As of 2025-11-06, the Relative Valuation of Design Therapeutics Inc (DSGN) is (16.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.55 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -347.6%.
The range of the Relative Valuation is (16.52) - (16.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 15.2x | 15.0x |
| Forward P/E multiples | 13.4x - 14.8x | 14.1x |
| Fair Price | (16.52) - (16.45) | (16.22) |
| Upside | -352.2% - -351.2% | -347.6% |
| Date | P/E |
| 2025-11-03 | -5.88 |
| 2025-10-31 | -6.01 |
| 2025-10-30 | -5.86 |
| 2025-10-29 | -5.82 |
| 2025-10-28 | -5.99 |
| 2025-10-27 | -6.25 |
| 2025-10-24 | -5.14 |
| 2025-10-23 | -5.11 |
| 2025-10-22 | -4.96 |
| 2025-10-21 | -5.05 |
| 2025-10-20 | -5.23 |
| 2025-10-17 | -5.15 |
| 2025-10-16 | -5.53 |
| 2025-10-15 | -6.02 |
| 2025-10-14 | -5.94 |
| 2025-10-13 | -5.82 |
| 2025-10-10 | -6.05 |
| 2025-10-09 | -6.39 |
| 2025-10-08 | -6.23 |
| 2025-10-07 | -5.82 |
| 2025-10-06 | -5.70 |
| 2025-10-03 | -5.48 |
| 2025-10-02 | -5.40 |
| 2025-10-01 | -6.09 |
| 2025-09-30 | -6.75 |
| 2025-09-29 | -6.14 |
| 2025-09-26 | -5.89 |
| 2025-09-25 | -5.48 |
| 2025-09-24 | -5.78 |
| 2025-09-23 | -5.40 |
| 2025-09-22 | -5.70 |
| 2025-09-19 | -5.43 |
| 2025-09-18 | -5.61 |
| 2025-09-17 | -5.34 |
| 2025-09-16 | -5.25 |
| 2025-09-15 | -5.26 |
| 2025-09-12 | -5.41 |
| 2025-09-11 | -5.35 |
| 2025-09-10 | -5.50 |
| 2025-09-09 | -5.96 |
| 2025-09-08 | -5.22 |
| 2025-09-05 | -5.79 |
| 2025-09-04 | -5.48 |
| 2025-09-03 | -5.35 |
| 2025-09-02 | -5.14 |
| 2025-08-29 | -4.96 |
| 2025-08-28 | -5.06 |
| 2025-08-27 | -4.75 |
| 2025-08-26 | -4.85 |
| 2025-08-25 | -4.66 |